Date(s) - September 22,2019
8:00 am - 1:00 pm
Dr. Martha M. Rumore, Pharm D., JD, MS, LLM, FAPhA
Touro College of Pharmacy
Dr. Martha Rumore is a pharmacist/attorney admitted to the NY, NJ, and DC bars. She has a Pharm D. from St. John’s University, a MS in Drug Information from Long Island University, a JD from CUNY School of Law, and an LLM in Intellectual Property from the Benjamin N. Cardozo School of Law. She is currently Of Counsel at the law firm of Sorell, Lenna & Schmidt, LLP in New York and a Clinical Pharmacist at Montefiore Medical Center in New York. At the law firm she focuses on pharmaceutical and medical device intellectual property including all aspects of patent law prosecution and transactional matters. She has over 15 years of law firm experience in the area of pharmaceutical intellectual property, especially generic pharmaceuticals. She has also worked in the pharmaceutical industry and hospital pharmacy, both at the Director level. She taught Pharmacy Law at both Long Island University and Touro College of Pharmacy for close to 20 years. In 2017, she won the Touro Faculty Research and Scholarship Award. Martha is a frequent lecturer and has over 200 publications and presentations. She is a Fellow and former Trustee of the American Pharmacists Association and in 2015 received the APhA-APPM Poster Merit Award. She is also a former member of the American Society for Pharmacy Law Board of Directors and received the 2015 Larry Simonsmeier Legal Writing Award. She has been elected to the Accreditation Council for Pharmacy Education (ACPE) International Commission. Most recently, she was appointed to a 6-year term on the ACPE Board of Directors.
ACPE # 0043-9999-18-020-L03-P and 0043-9999-18-021-L05-P
1. Examine recent legislative, legal, and regulatory changes impacting pharmacists on the state and federal level.
2. Describe recent court cases that are relevant to pharmacy practice and how those cases may affect the attendee’s behavior in providing pharmacy services.
3. Evaluate the current status of initiatives to recognize pharmacists as health care providers.
4. Describe the continuum of pharmacist prescriptive authority via Collaborative Practice Agreement Laws and State Protocols.
5. Recognize efforts to prevent medication misadventures.
6. Describe activities of pharmacists across practice settings to study and prevent medication errors.
7. Interpret recent pharmacy case law pertaining to medication errors and underlying theories of liability.
8. Identify best practices to decrease potential liability from medication errors.